110 related articles for article (PubMed ID: 10552081)
1. The time course of metabolites in human plasma after 6-[(18)F]fluoro-l-m-tyrosine administration.
Wahl LM; Chen JJ; Thompson M; Chirakal R; Nahmias C
Eur J Nucl Med; 1999 Nov; 26(11):1407-12. PubMed ID: 10552081
[TBL] [Abstract][Full Text] [Related]
2. A probe for intracerebral aromatic amino-acid decarboxylase activity: distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain.
Nahmias C; Wahl L; Chirakal R; Firnau G; Garnett ES
Mov Disord; 1995 May; 10(3):298-304. PubMed ID: 7651447
[TBL] [Abstract][Full Text] [Related]
3. Visualization of dopamine nerve terminals in monkey by positron emission tomography using 4-[18F]fluoro-L-m-tyrosine.
Hayase N; Tomiyoshi K; Watanabe K; Horikoshi S; Hirato M; Shibasaki T; Ohye C
Stereotact Funct Neurosurg; 1994; 62(1-4):191-6. PubMed ID: 7631066
[TBL] [Abstract][Full Text] [Related]
4. 6-[18F]fluoro-L-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates.
Jordan S; Eberling JL; Bankiewicz KS; Rosenberg D; Coxson PG; VanBrocklin HF; O'Neil JP; Emborg ME; Jagust WJ
Brain Res; 1997 Mar; 750(1-2):264-76. PubMed ID: 9098552
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of 6-[
Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
[TBL] [Abstract][Full Text] [Related]
6. Equilibration of 6-[18F]fluoro-L-m-tyrosine between plasma and erythrocytes.
Nahmias C; Wahl LM; Amano S; Asselin MC; Chirakal R
J Nucl Med; 2000 Oct; 41(10):1636-41. PubMed ID: 11037992
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA.
DeJesus OT; Endres CJ; Shelton SE; Nickles RJ; Holden JE
J Nucl Med; 1997 Apr; 38(4):630-6. PubMed ID: 9098215
[TBL] [Abstract][Full Text] [Related]
8. 4-[18F]fluoro-L-m-tyrosine: an L-3,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography.
Melega WP; Perlmutter MM; Luxen A; Nissenson CH; Grafton ST; Huang SC; Phelps ME; Barrio JR
J Neurochem; 1989 Jul; 53(1):311-4. PubMed ID: 2786055
[TBL] [Abstract][Full Text] [Related]
9. A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease.
Li CT; Palotti M; Holden JE; Oh J; Okonkwo O; Christian BT; Bendlin BB; Buyan-Dent L; Harding SJ; Stone CK; DeJesus OT; Nickles RJ; Gallagher CL
Synapse; 2014 Aug; 68(8):325-31. PubMed ID: 24710997
[TBL] [Abstract][Full Text] [Related]
10. A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease.
Gallagher CL; Christian BT; Holden JE; Dejesus OT; Nickles RJ; Buyan-Dent L; Bendlin BB; Harding SJ; Stone CK; Mueller B; Johnson SC
Mov Disord; 2011 Sep; 26(11):2032-8. PubMed ID: 21638324
[TBL] [Abstract][Full Text] [Related]
11. Localization of trapping of 6-[(18)F]fluoro-L-m-tyrosine, an aromatic L-amino acid decarboxylase tracer for PET.
Brown WD; DeJesus OT; Pyzalski RW; Malischke L; Roberts AD; Shelton SE; Uno H; Houser WD; Nickles RJ; Holden JE
Synapse; 1999 Nov; 34(2):111-23. PubMed ID: 10502310
[TBL] [Abstract][Full Text] [Related]
12. Modeling of fluorine-18-6-fluoro-L-Dopa in humans.
Wahl L; Nahmias C
J Nucl Med; 1996 Mar; 37(3):432-7. PubMed ID: 8772639
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
Kanazawa M; Ohba H; Harada N; Kakiuchi T; Muramatsu S; Tsukada H
J Nucl Med; 2016 Feb; 57(2):303-8. PubMed ID: 26564319
[TBL] [Abstract][Full Text] [Related]
15. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.
Bankiewicz KS; Eberling JL; Kohutnicka M; Jagust W; Pivirotto P; Bringas J; Cunningham J; Budinger TF; Harvey-White J
Exp Neurol; 2000 Jul; 164(1):2-14. PubMed ID: 10877910
[TBL] [Abstract][Full Text] [Related]
16. Aromatic L-amino acid decarboxylase (AAAD) inhibitors as carcinoid tumor-imaging agents: synthesis of 18F-labeled alpha-fluoromethyl-6-fluoro-m-tyrosine (FM-6-FmT).
Murali D; Flores LG; Roberts AD; Nickles RJ; DeJesus OT
Appl Radiat Isot; 2003 Oct; 59(4):237-43. PubMed ID: 14522231
[TBL] [Abstract][Full Text] [Related]
17. Radiofluorinated L-m-tyrosines: new in-vivo probes for central dopamine biochemistry.
Barrio JR; Huang SC; Yu DC; Melega WP; Quintana J; Cherry SR; Jacobson A; Namavari M; Satyamurthy N; Phelps ME
J Cereb Blood Flow Metab; 1996 Jul; 16(4):667-78. PubMed ID: 8964807
[TBL] [Abstract][Full Text] [Related]
18. Effect of 6-fluoro-m-tyrosine on dopamine release and metabolism in rat striatum using in vivo microdialysis.
Stein TD; DeJesus OT
Brain Res; 2000 Nov; 884(1--2):192-5. PubMed ID: 11082501
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
Melega WP; Luxen A; Perlmutter MM; Nissenson CH; Phelps ME; Barrio JR
Biochem Pharmacol; 1990 Jun; 39(12):1853-60. PubMed ID: 2112915
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
